Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
09/2010
09/23/2010US20100239596 Grp78 and tumor angiogenesis
09/23/2010US20100239595 Equine antibodies against bacillus anthracis for passive immunization and treatment
09/23/2010US20100239594 Compositions and methods for production of immunoglobulins
09/23/2010US20100239593 Rsv-specific binding molecules and means for producing them
09/23/2010US20100239592 Methods of analysis and detecting molecular defects in transcobalamin i deficiency
09/23/2010US20100239591 Monoclonal antibody for app
09/23/2010US20100239590 Joint destruction biomarkers for anti-il-17a therapy of inflammatory joint disease
09/23/2010US20100239589 Methods and Compositions for Ameliorating Diabetes and Symptoms Thereof
09/23/2010US20100239588 The functional epitope of osteopontin, the anti-osteopontin monoclonal antibody and use thereof
09/23/2010US20100239587 Peptides, mimetics and antibodies of erbB, TNF, and IgSF receptors; for preventing, treating, and diagnosing mammalian cancer tumors
09/23/2010US20100239586 Procalin polypeptides, antigens, and methods of use
09/23/2010US20100239585 Antibodies Against Mammalian Metapneumovirus
09/23/2010US20100239584 Glycoconjugates and use thereof as vaccine against shigella flexneri serotype 3a and x
09/23/2010US20100239583 Antibodies against flagellin and uses thereof
09/23/2010US20100239582 Dual Specificity Antibody Fusions
09/23/2010US20100239581 Kidney disease targets and uses thereof
09/23/2010US20100239580 Taci-immunoglobulin fusion proteins for treatment of optic neuritis
09/23/2010US20100239579 CD47 Related Compositions and Methods for Treating Immunological Diseases and Disorders
09/23/2010US20100239578 Modulation of sirp-alpha - cd47 interaction for increasing human hematopoietic stem cell engraftment and compounds therefor
09/23/2010US20100239577 Anti-glypican-3 antibody having improved kinetics in plasma
09/23/2010US20100239576 Amino ester derivatives, sailts thereof and methods of use
09/23/2010US20100239575 Anti-cd40 antibodies and uses thereof
09/23/2010US20100239574 High potency recombinant antibodies and method for producing them
09/23/2010US20100239573 METHOD OF INHIBITING COMPLEMENT ACTIVATION WITH FACTOR Bb SPECIFIC ANTIBODIES
09/23/2010US20100239572 Methods for treating and preventing gi syndrome and graft versus host disease
09/23/2010US20100239571 CD30 Binding Agents and Uses Thereof
09/23/2010US20100239570 Moncolonal amyloid beta (abeta) - specific antibody and uses thereof
09/23/2010US20100239569 Method Of Treating Disorders Of The Cardiovascular System And A Pharmaceutical Agent
09/23/2010US20100239568 Diagnostics and treatments for tumors
09/23/2010US20100239567 Antibody Formulation
09/23/2010US20100239566 Enigma-mdm2 interaction and uses thereof
09/23/2010US20100239565 Methods of treatment of skin ulcers
09/23/2010US20100239564 Novel human growth factors
09/23/2010US20100239563 Pharmaceutical composition for the prophylaxis and/or treatment of viral diseases
09/23/2010US20100239562 Kv CHANNELS IN NEURODEGENERATION AND NEUROPROTECTION
09/23/2010US20100239548 Isolation and Identification of T Cells
09/23/2010US20100239530 Ifnar2 mutants, their production and use
09/23/2010US20100239527 2,3-substituted azaindole derivatives for treating viral infections
09/23/2010US20100239526 Substituted imidazolyl-5,6-dihydrobenzo[n]isoquinoline compounds
09/23/2010US20100239525 Substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds
09/23/2010US20100239522 Chemotherapeutic for inducing an msh2-dependent apoptotic pathway
09/23/2010US20100239517 Novel conjugated proteins and peptides
09/23/2010CA2851737A1 Alpha-4beta-7 heterodimer specific antagonist antibody
09/23/2010CA2769276A1 Humanised antibodies with anti-tumour activity
09/23/2010CA2755973A1 Production of recombinant proteins in ciliates and uses thereof
09/23/2010CA2755821A1 Human immunodeficiency virus (hiv) -neutralizing antibodies
09/23/2010CA2755790A1 Vaccination methods
09/23/2010CA2755782A1 Biomarkers and uses thereof
09/23/2010CA2755686A1 Methods and compositions for bi-specific targeting of cd19/cd22
09/23/2010CA2755509A1 Agents and methods for tissue repair and regeneration
09/23/2010CA2755342A1 Neil3 peptides and vaccines including the same
09/23/2010CA2755336A1 Carrier immunoglobulins and uses thereof
09/23/2010CA2755257A1 Replication-defective flavivirus vaccine vectors against respiratory syncytial virus
09/23/2010CA2748889A1 Compositions and methods for blood-brain barrier delivery of igg-decoy receptor fusion proteins
09/22/2010EP2230517A1 OVR110 antibody compositions and methods of use
09/22/2010EP2230320A1 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
09/22/2010EP2230308A1 Antibody molecules having specificity for human tumor necrosis factor alpha, and use thereof
09/22/2010EP2230307A1 Neutrokine alpha
09/22/2010EP2230300A1 Polypeptide having enhanced effector function
09/22/2010EP2230299A1 Novel cytokine ZCYTOR17 ligand
09/22/2010EP2230256A1 Antibodies with simultaneous subsite specificities to protein and lipid epitopes
09/22/2010EP2230254A2 Anti-IGFR1 antibody therapeutic combinations
09/22/2010EP2230250A1 Anti-hiv monoclonal antibody
09/22/2010EP2230249A2 Antigen/antibody or ligand/receptor glycosylated specificity exchangers
09/22/2010EP2230246A1 Arterivirus glycoprotein 5 virus-like particles
09/22/2010EP2229956A1 Multimeric constructs
09/22/2010EP2229955A1 Fibroblast growth factor receptor-1 inhibitors and methods of treatment using the same
09/22/2010EP2229954A1 Capsular polysaccharide solubilisation and combination vaccines
09/22/2010EP2229953A1 Transfection of blood cells with mRNA for immune stimulation and gene therapy
09/22/2010EP2229432A1 Antimicrobial activity of bacteriocin-producing lactic acid bacteria
09/22/2010EP2229410A2 Aglycosylated immunoglobulin mutants
09/22/2010EP1962094B1 Detecting agent and therapeutic agent for highly malignant breast cancer
09/22/2010EP1639014B1 Aglycosyl anti-cd154 (cd40 ligand) antibodies and uses thereof
09/22/2010EP1554301B1 Dengue vaccine containing a common 30 nucleotide deletion in the 3'-utr of dengue types 1 and 2.
09/22/2010EP1194449B1 Inhibitors of memapsin 2 and use thereof
09/22/2010CN101842497A Detection of influenza virus
09/22/2010CN101842490A Antigenic compositions and use of same in the targeted delivery of nucleic acids
09/22/2010CN101842486A Immunology treatment for biofilms
09/22/2010CN101842390A Antibodies against RAMP3
09/22/2010CN101842389A Anti-cd20 therapeutic compositions and methods
09/22/2010CN101842388A Humanized antibodies against the beta-amyloyd peptide
09/22/2010CN101842117A Anti-IGF-1R antibodies and uses thereof
09/22/2010CN101842116A Compositions that bind multiple epitopes of IGF-1R
09/22/2010CN101842115A Humanized anti-CXCR5 antibodies, derivatives thereof and their uses
09/22/2010CN101842114A Methods and compositions for treatment and diagnosis of fibrosis, tumor invasion, angiogenesis, and metastasis
09/22/2010CN101842113A Immune response inducer
09/22/2010CN101838660A Mycobacterium tuberculosis recombinant fusion protein and application thereof
09/22/2010CN101838639A Schistosoma japonicum proteasome Alpha5 subunit recombinant antigen and expression, purification and application thereof
09/22/2010CN101838627A Recombination salmonella choleraesuis and bivalent genetic engineering vaccine and preparation method
09/22/2010CN101838611A Recombinant plasmodium for expressing exogenous gene and application thereof
09/22/2010CN101838328A Anti-vegf antibodies
09/22/2010CN101838325A Antigen-presenting protein for swines and encoding gene and application thereof
09/22/2010CN101838319A Asia 1-type FMDV compound multiepitope
09/22/2010CN101838318A Anti-HIV-I polypeptide and coding sequence and use thereof
09/22/2010CN101838317A Mimic short peptide 11B of endothelial cell growth factor VEGF antigen epitope and application thereof
09/22/2010CN101838313A Mimic short peptide 9B of endothelial cell growth factor VEGF antigen epitope and application thereof
09/22/2010CN101838312A Mimic short peptide 12B of endothelial cell growth factor VEGF antigen epitope and application thereof
09/22/2010CN101838311A Mimic short peptide 7B of endothelial cell growth factor VEGF antigen epitope and application thereof
09/22/2010CN101838310A Basic fibroblast growth factor epitope simulative peptide T3 and application thereof
09/22/2010CN101837134A Chronic myeloid leukemia DNA vaccine BCR/ABL-pIRES-SEA and preparation method and application thereof
1 ... 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 ... 1823